Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Schizophrenia Research. Cognition
|
September 18, 2024
Training individuals with schizophrenia to gain volitional control of the theory of mind network with real-time fMRI: A pilot study
Elizabeth A Kruse, Abhishek Saxena, Bridget J Shovestul, et al.
The Journal of Clinical Psychiatry
|
May 28, 2004
Prevalence of diabetes mellitus among outpatients with severe mental disorders receiving atypical antipsychotic drugs
J Steven Lamberti, John F Crilly, Kumar Maharaj, et al.
The American Journal of Psychiatry
|
July 4, 2006
Prevalence of the metabolic syndrome among patients receiving clozapine
J Steven Lamberti, David Olson, John F Crilly, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 10, 2007
A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia
Donald C Goff, J Steven Lamberti, Andrew C Leon, et al.
Psychiatric Services (Washington, D.C.)
|
September 6, 2022
Affordability of Forensic Assertive Community Treatment Programs: A Return-on-Investment Analysis
Daniel Maeng, Zhi-Yang Tsun, Eric Lesch, et al.
The Journal of Clinical Psychiatry
|
July 15, 2005
Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates
J Steven Lamberti, G Oana Costea, David Olson, et al.
Journal of Substance Abuse Treatment
|
October 1, 2013
Meeting health and psychological needs of women in drug treatment court
Diane S Morse, Catherine Cerulli, Precious Bedell, et al.
Schizophrenia Research
|
January 14, 2010
Criminal behavior among persons with schizophrenia in rural China
Mao-Sheng Ran, Peng-Yu Chen, Zhi-Gang Liao, et al.
JAMA Psychiatry
|
March 8, 2013
Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia
Joshua L Roffman, J Steven Lamberti, Eric Achtyes, et al.
Schizophrenia Research
|
February 26, 2013
Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trial
T Scott Stroup, Matthew J Byerly, Henry A Nasrallah, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Schizophrenia Research. Cognition
|
September 18, 2024
Training individuals with schizophrenia to gain volitional control of the theory of mind network with real-time fMRI: A pilot study
Elizabeth A Kruse, Abhishek Saxena, Bridget J Shovestul, et al.
The Journal of Clinical Psychiatry
|
May 28, 2004
Prevalence of diabetes mellitus among outpatients with severe mental disorders receiving atypical antipsychotic drugs
J Steven Lamberti, John F Crilly, Kumar Maharaj, et al.
The American Journal of Psychiatry
|
July 4, 2006
Prevalence of the metabolic syndrome among patients receiving clozapine
J Steven Lamberti, David Olson, John F Crilly, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 10, 2007
A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia
Donald C Goff, J Steven Lamberti, Andrew C Leon, et al.
Psychiatric Services (Washington, D.C.)
|
September 6, 2022
Affordability of Forensic Assertive Community Treatment Programs: A Return-on-Investment Analysis
Daniel Maeng, Zhi-Yang Tsun, Eric Lesch, et al.
The Journal of Clinical Psychiatry
|
July 15, 2005
Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates
J Steven Lamberti, G Oana Costea, David Olson, et al.
Journal of Substance Abuse Treatment
|
October 1, 2013
Meeting health and psychological needs of women in drug treatment court
Diane S Morse, Catherine Cerulli, Precious Bedell, et al.
Schizophrenia Research
|
January 14, 2010
Criminal behavior among persons with schizophrenia in rural China
Mao-Sheng Ran, Peng-Yu Chen, Zhi-Gang Liao, et al.
JAMA Psychiatry
|
March 8, 2013
Randomized multicenter investigation of folate plus vitamin B12 supplementation in schizophrenia
Joshua L Roffman, J Steven Lamberti, Eric Achtyes, et al.
Schizophrenia Research
|
February 26, 2013
Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trial
T Scott Stroup, Matthew J Byerly, Henry A Nasrallah, et al.
Page
of 6